Bony Trauma Extremity System (BTES) Screw Range, NX Nail

K230118 · Field Orthopaedics Pty, Ltd. · HWC · Feb 16, 2023 · Orthopedic

Device Facts

Record IDK230118
Device NameBony Trauma Extremity System (BTES) Screw Range, NX Nail
ApplicantField Orthopaedics Pty, Ltd.
Product CodeHWC · Orthopedic
Decision DateFeb 16, 2023
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 888.3040
Device ClassClass 2
AttributesTherapeutic, Pediatric

Intended Use

The Field Orthopaedics BTES Screw Range is intended for use in the fixation of fractures, osteotomies, and arthrodesis, appropriate for the size of the device, in adults and in both, children (2-12 years) and adolescents (12- 21 years), in which growth plates have fused or in which growth plates will not be crossed by screw fixation. The FO Fenestrated Screws are not for the delivery of bone graft, bone cement, or bone void filler. The Field Orthopaedics BTES Plate Range and Plate Screws are intended for use in the fixation of fractures, osteotomies, and arthrodesis of the hand and other small bones. The system may be used in both adults and pediatric patients.

Device Story

The Bony Trauma Extremity System (BTES) is an orthopedic trauma system consisting of metallic bone screws and plates. The NX Nail System is a line extension of the existing BTES screw range. Implants are manufactured from Titanium alloy ELI (ASTM F136). The system is used by surgeons in clinical settings for the fixation of fractures, osteotomies, and arthrodesis. The devices are provided either non-sterile or sterile (gamma radiation). The system includes associated surgical instruments for implantation. The device functions as a mechanical fastener to stabilize bone segments, facilitating healing. The surgeon selects the appropriate screw size and type based on the clinical presentation. The system provides mechanical stability to the fracture site, which benefits the patient by promoting bone union and restoring function.

Clinical Evidence

Bench testing only. Engineering analyses confirmed bending strength and pull-out force were within acceptable limits relative to the predicate. Insertion, removal, and maximum torque testing met acceptance criteria. Cleaning, packaging, and sterilization validation met requirements. Surgeon user evaluation confirmed intended functionality. Biocompatibility of implants and instruments was assessed and met criteria.

Technological Characteristics

Materials: Titanium alloy ELI (ASTM F136) for screws; medical grade stainless steel and anodized aluminum for instruments. Design: Non-compressive headless screws, 2.0-5.0mm diameter, 12-90mm length. Connectivity: None. Sterilization: Gamma radiation (for sterile components).

Indications for Use

Indicated for fixation of fractures, osteotomies, and arthrodesis in adults, children (2-12 years), and adolescents (12-21 years) where growth plates are fused or not crossed by fixation. Fenestrated screws are contraindicated for delivery of bone graft, cement, or void filler.

Regulatory Classification

Identification

A smooth or threaded metallic bone fixation fastener is a device intended to be implanted that consists of a stiff wire segment or rod made of alloys, such as cobalt-chromium-molybdenum and stainless steel, and that may be smooth on the outside, fully or partially threaded, straight or U-shaped; and may be either blunt pointed, sharp pointed, or have a formed, slotted head on the end. It may be used for fixation of bone fractures, for bone reconstructions, as a guide pin for insertion of other implants, or it may be implanted through the skin so that a pulling force (traction) may be applied to the skeletal system.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA text logo on the right. The text logo has the FDA acronym in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue. February 16, 2023 Field Orthopaedics Pty Ltd Jillianne Mckenzie Vice President, Regulatory Affairs 30 Florence St Teneriffe, QLD 4005 Australia Re: K230118 Trade/Device Name: Bony Trauma Extremity System (BTES) Screw Range Regulation Number: 21 CFR 888.3040 Regulation Name: Smooth Or Threaded Metallic Bone Fixation Fastener Regulatory Class: Class II Product Code: HWC Dated: January 16, 2023 Received: January 17, 2023 Dear Jillianne Mckenzie: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely. Shumaya Ali-S Shumaya Ali, M.P.H. Assistant Director DHT6C: Division of Restorative, Repair and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ## Indications for Use 510(k) Number (if known) K230118 Device Name Bony Trauma Extremity System (BTES) Screw Range Indications for Use (Describe) The Field Orthopaedics BTES Screw Range is intended for use in the fixation of fractures, and arthrodesis. appropriate for the size of the device, in adults and in both, children (2-12 years) and adolescents (12- 21 years), in which growth plates have fused or in which growth plates will not be crossed by screw fixation. The FO Fenestrated Screws are not for the delivery of bone graft, bone cement, or bone void filler. The Field Orthopaedics BTES Plate Range and Plate Screws are in the fixation of fractures, osteotomies, and arthrodesis of the hand and other small bones. The system may be used in both adults and pediatric patients. | Type of Use (Select one or both, as applicable) | | |------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | <span style="font-family: Arial;"> <span style="font-size: 10pt;"> </span> </span> <span style="font-family: Symbol;"> <span style="font-size: 10pt;"> </span> </span> <span style="font-family: Arial;"> <span style="font-size: 10pt;">Prescription Use (Part 21 CFR 801 Subpart D)</span> </span> | <span style="font-family: Arial;"> <span style="font-size: 10pt;"> </span> </span> <span style="font-family: Symbol;"> <span style="font-size: 10pt;"> </span> </span> <span style="font-family: Arial;"> <span style="font-size: 10pt;">Over-The-Counter Use (21 CFR 801 Subpart C)</span> </span> | #### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ #### K230118 ### Special 510(k) Summary - Field Orthopaedics Bony Trauma Extremity System Screw Range, NX Nail System In accordance with 21 CFR 807.92 of the Federal Code of Regulations, the following information is a summary of safety and effectiveness of the Bony Trauma Extremity System (BTES) Screw Range, NX Nail System. ### A. SUBMITTER'S INFORMATION | Submitter Name: | BioVera, Inc. | |---------------------|------------------------------------------------------------| | Submitter Address: | 65 Promenade Saint-Louis, NDIP, Québec, J7W 3J6,<br>CANADA | | Contact Person: | Robert A. Poggie, PhD | | Phone & Fax Number: | 514-901-0796 | | Date of Submission: | January 16, 2023 | #### B. DEVICE IDENTIFICATION & MANUFACTURER | Manufacturer Name: | Field Orthopaedics Pty Ltd | |-----------------------|----------------------------------------------------| | Manufacturer Address: | 30 Florence Street, Teneriffe 4005 QLD AUSTRALIA | | Registration Number: | 3015131017 | | Contact Name: | Jillianne McKenzie | | Title: | Vice President, Regulatory Affairs | | Device Trade Names: | Bony Trauma Extremity System (BTES) Screw Range | | Device Common Names: | Screw, Fixation, Bone | | Classification Names: | Smooth or threaded metallic bone fixation fastener | | Classification Codes: | HWC - Class II | | Classification Panel: | Orthopedic | | Regulation Numbers: | 21 CFR sections 888.3040 | PRIMARY PREDICATE DEVICE K200043 Field Orthopaedics Bony Trauma Extremity System (BTES) Plate Range and Plate Screws and Field Orthopaedics Bony Trauma Extremity System (BTES) Screw Range {4}------------------------------------------------ ## DEVICE DESCRIPTION The Field Orthopaedics Bony Trauma Extremity System (BTES) is an extremity trauma system consisting of a range of screws and a range of plates cleared in K200043. The BTES screw range consists of a range of screws intended for standalone use, and a range of screws intended to be used with the BTES plate range. The standalone screw range consists of 1.2 mm solid, partially threaded screws of various lengths; 1.5 – 5.0 mm cannulated, partially threaded screws in both headless and headed designs of various lengths; and 2.0 - 3.0 mm Cannulated, fenestrated, partially threaded screws in both headless and headed designs of various lengths. The range of screws intended to be used with the BTES plate range consists of 1.2, 1.5, and 2.0 mm solid, fully-threaded screws of various lengths. The purpose of this Special 510(k) device modification is to notify FDA of the sterile NX Nail System, which is a line extension to the BTES Screw Range described above and cleared in K200043. NX Nail implants are made from the same titanium alloy using the same manufacturing processes as BTES implants, are non-compressive in design, and are available in lengths ranging from 12 to 90 mm and diameters ranging from 2.0 to 5.0 mm. NX Nail implants are offered nonsterile and sterile (gamma radiation). This Special 510(k) also includes added instruments for implanting NX Nail devices. Materials: All BTES screws in the Screw Range are made with Titanium alloy ELI (as per ASTM F136). All plates are available as identical configurations in both Titanium alloy ELI (as per ASTM F136) and CP Titanium (ISO 5832-2). Instruments are made from medical grades stainless steel, anodized aluminum, and marked with epoxy resin. ## INDICATIONS FOR USE The Field Orthopaedics BTES Screw Range is intended for use in the fixation of fractures, osteotomies, and arthrodesis, appropriate for the size of the device, in adults and in both, children (2-12 years) and adolescents (12- 21 years), in which growth plates have fused or in which growth plates will not be crossed by screw fixation. The FO Fenestrated Screws are not for the delivery of bone graft, bone cement, or bone void filler. The Field Orthopaedics BTES Plate Range and Plate Screws are intended for use in the fixation of fractures, osteotomies, and arthrodesis of the hand and other small bones. The system may be used in both adults and pediatric patients. {5}------------------------------------------------ # TECHNOLOGICAL CHARACTERISTICS The Bony Trauma Extremity System (BTES) Screw Range, NX Nail System line extension, is substantially equivalent to the primary predicate device, the Field Orthopaedics Bony Trauma Extremity System (BTES), because they are manufactured from the same materials using the same manufacturing processes, and possess the same indications and intended uses. The NX Nail System line extension is within the design scope, intended and indicated uses for the BTES, and the updated instruments are within the scope of the cleared indicated use. The table below compares the technological characteristics. | | Subject Device, BTES Screw Range, NX<br>Nail System, K230118 | Primary Predicate Device, FO BTES<br>Screw Range and Plate Range, K200043 | |--------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Reg, product code | 888.3040, HWC | 888.3040, HWC; 888.3030, HRS | | Indication For Use | The Field Orthopaedics BTES Screw<br>Range is intended for use in the fixation of<br>fractures, osteotomies, and arthrodesis,<br>appropriate for the size of the device, in<br>adults and in both, children (2-12 years)<br>and adolescents (12- 21 years), in which<br>growth plates have fused or in which<br>growth plates will not be crossed by screw<br>fixation. The FO Fenestrated Screws are<br>not for the delivery of bone graft, bone<br>cement or bone void filler.<br>The Field Orthopaedics BTES Plate Range<br>and Plate Screws are intended for use in<br>the fixation of fractures, osteotomies, and<br>arthrodesis of the hand and other small<br>bones. The system may be used in both<br>adults and pediatric patients. | The Field Orthopaedics BTES Screw<br>Range is intended for use in the fixation of<br>fractures, osteotomies, and arthrodesis,<br>appropriate for the size of the device, in<br>adults and in both, children (2-12 years)<br>and adolescents (12- 21 years), in which<br>growth plates have fused or in which<br>growth plates will not be crossed by screw<br>fixation. The FO Fenestrated Screws are<br>not for the delivery of bone graft, bone<br>cement or bone void filler.<br>The Field Orthopaedics BTES Plate Range<br>and Plate Screws are intended for use in<br>the fixation of fractures, osteotomies, and<br>arthrodesis of the hand and other small<br>bones. The system may be used in both<br>adults and pediatric patients. | | Type | Non-Compressive Headless | Compression Head and Headless | | Cannulated | Yes | Yes and No | | Self-Drilling | Yes | Yes | | Inner/Outer Diameter<br>For compression head<br>and headless | NX Nail: | Fenestrated:<br>2.0 to 3.0mm diam.<br>6 to 60mm long<br><br>Micro:<br>1.2 to 2.0 mm diam.<br>6 to 16 mm long<br><br>Nano:<br>1.2 mm diam.<br>6 to 20 mm long | | Length<br>For compression head<br>and headless | 2.0 to 5.0mm in diameter,<br><br>12 to 90mm in length | Compression:<br>1.2 to 5.0 mm<br>6 to 90 mm long | | Material | Titanium Alloy (F136) | Titanium Alloy (F136) | | Sterile | Yes and No (NX Nail); No (Remaining<br>components of BTES Screw Range, NX Nail<br>System) | No (BTES in K200043) | {6}------------------------------------------------ Comparison of the technological characteristics and indicated use of the subject and primary predicate devices demonstrate that the subject device, the BTES Screw Range, NX Nail System, is substantially equivalent to the primary predicate device. ### PERFORMANCE DATA Verification and validation (V&V) activities included the following: - · Engineering analyses of NX Nail implants for bending strength and pull out force relative to cleared BTES demonstrated no new worst case, - · Insertion, removal, and maximum torques of NX Nail implants were measured and met acceptance criteria, - · Cleaning, packaging, and sterilizations for the sterile NX Nail met acceptance criteria. - · Surgeon user evaluation demonstrated the NX Nail devices to work as intended, and - · Assessment of biocompatibility of instruments and implants, packaging, and distribution requirements for the subject devices met acceptance criteria. ## CONCLUSION The data presented in this Special 510(k) device modification show the BTES Screw Range, NX Nail System, is substantially equivalent to the legally marketed primary predicate device, the Field Orthopaedics Bony Trauma Extremity System (BTES). It has the same or similar technological characteristics, materials, sizes, manufacturing processes, and principles of operation as the primary predicate device.
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...